Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (2763)	11/13/1997 7:13:00 PM
From: Izzy	Read Replies (1) \| Respond to of 6136

Henry, thanks for the interesting info. BTW, what progress has LGND made in developing a treatment/cure for HIV? Congratulations, LGND has reported slightly increased revenues but increased net loss. What is LGND presenting at the Seattle Biotech Forum on 12-13-97? Or maybe I should go over to the LGND thread. PS: Have noted LGND price stock going down; why?

To: Henry Niman who wrote (2763)	11/13/1997 7:46:00 PM
From: JOHN W.	Read Replies (2) \| Respond to of 6136

The cocktail has not been considered a cure for a very long time. What is your news or point? That the cocktail works for extended periods of time and that patients must continue to take/buy these drugs or die? What do you propose instead of combination therapy, DEATH? What are the current altrnatives now and 10 yrs from now? Thanks for the very old news. I cant wait for your chemokines post. P.S. Why all the insider selling at LGND? I understand several of their key scientist are bailing out of the company. Maybe they are the ones selling.